Charitv number: 1135.119 Company number: 07003983 British .Societ.v For Paediatric Endocrlnoln￿V and Diahetes (A compan). limited bv guarantee Trustee.s' annual report and financial slatements for the year ended 31 August 2024 British Societv For Paediatric Endocrinolo&i' and Diabetes {A companv limited bv guarantee) Contents Pa%e LL&>al and Jdmini%trativL' Inlortnalifin I'ni%lLL4' rLPUrt 2-10 IndLPLndLnl LxJmiiiir%' rL'PI)n li St.'IlL'ITiLnl (?r rinanLiJI JLliviliL 12 BdlanLL shLLt 13-14 ,Nvlc% io Ihe findncial staleJi]eni 15-20 British Syociety For Paediatric Endocrinolvgy and Diabetes (A company limited bv %uarantee) Legal and administratii'e inforniation Charity registration numher 1.15319 Company re%islration number 071N)391t3 Business addre& clo PaLJIa￿lL Endi)crine DlP.￿rnCnt E Floor Martin Iving LL'Ld% ChildrLn'S Ho%pilJl LrLds LSI AEX Re%istered office Llu R￿,￿ Goodman LLP g CartL'r London Eng'land LC4V 5LQ Truslees Dr Fiona KLgJn lapwJinlLd 9 ovi'mbLr 202.3 Dr Sabah Ali'i Iresigncd g Novcn)bcr ?11?31 Dr T*ibithJ RandLII IrL%igiiLd 9 OL-tobLI •11241 Dr Melanie Kershaw. (re%i¥ned 9 October 21}?41 Dt Taldt N.lusbiJq ?{)?41 {Jpp(iinted 9 October . Dr senthilk-unl￿ K:Iruppanan%enniappan I:Ippvintcd 9 OLI()ber ?1)24) Accountants. LefilL!' Roi¥L & Compan! SeLC)iiiJ Fl()()r 117 KLntoii Ruad H￿oW Miijdlesex HAA IIAH Rlankcrs Lloi'd% Bank. PIC IILaih 32 - 34 Alcester Road Souih "ngT4 Hcaih Birniingham B147PU Pa%e British Societi. For Paediatric EndocrinOlo￿V and Diabetes (A companTr' limited bv guarantee) Repi)rt (>f the Iru%tees' (inci)rp(>rating the direclors, reporti tor the vear ended 31 Augusl 2024 The Irusiee% pre%eni iheir repnn and ihe financial %iaiem¢nis ol Ihe chariiy fnr ihe vear ended 11 August )11?4. The Iru.%lLLS hdl'L :Idc)ptLd thL prol'isions nf thL' SLItLmLnt nt RLLnn)InLndLd PTditiLL ISORPI 'ALL()unhno :￿d RLPOrtin¥¥ by CharitiL'% I I,"K.8 111, I iii prLpanll￿ thL &innuJl fLPC>rt and t'iiianiiJl %lalLii)Lnl% i?t thL LhLirit)'. ThL diiLLtI)r% ot thL' ihiiritablL Ll)li)p.'InN' :IrL It% tru%tLL% 14ir thi purp(IsLN vt ih'irilN' laii.. ThL dirLitor% ￿-hij %Lrn'Ld durin¥ thL ￿'L￿ and up tiTr tiiL ddtL l)f thi% fLP(Trn ar¥. NLI ()ut i)n pagL I. Struclure. goTrernanLe and mana%ement Thi BritiNh Sc)IlLIN' For PaLdidiriL EndiKrinnlo¥i' and DidbLII% 1% Lonililuiid bN' a DL'L'd of TnL%I dnd 1% a rLgi%lLfLd Lharit }' No I1_4.5_41 (J. The ch'irit!, ch:Ineed il.s %iaius lo a cnnip')D)' limiled bv guarantee Iroiii111 Sepieiiiber ?11111. ()bjeclii'e% and actii'ities "IThL dims uf thL Lh￿1V lu JJi'*lnLC LduiJlion in PilL.di¢ilriL LndoiiinolL7b)' rLldled %ubjLLl¥ by prL)IiiulingT fLSLdfLh and di%%¢'ii)InJlin¥* thL U.SL.lul rL.suItN uf SULh rL'SL'JfLh. In kLLpin¥ with th¢ aims. thi .Sth iLtJ' shtill h4i'L rhL folloiving pvw'ers-. '[(} .'IrrJnLL and priividL lor ihe h()Idingi lif rnLLiinbiN. ILLturL% and %Linin￿￿. 'I'u PWLuri tu hi Ii'niiLn and priiil. puhlish. IN%UL LifLuItiiL yaluiluu%l)' ur uihL TW'ISL SULh PJPLIS. PiriodiLal%. PJTnphlLl% ur i>ihir duLuiiiLnts. -3. Til r.'ii¥e lunds 'ind IL) invile .Ind reieii'e LiJnlTihutii)n¥ fri)iii.'InN perM)n i)T per%ibn% iNh:Ilxi)ei'er b). Iv-lv i)[ subsiriplii)ns 'Lnd uiher%% i.4e pru% ided ihai ihe Suii¢l) %Fh-Ill nul und¢ridke 4n)' peri)￿en1 Jiljl'iiie% iii rai.%ing lund4 fur il primdri. lh￿lIable ubjeiliNes. 4. To Looperale. ￿%%0(1￿1e or affili')le wilh anN' other ¥h￿table in%liiuiion%. s 'riTr Jii all %ULh (TrihLr laivlul thing% a% are nc￿￿￿5arV lur thL atlaininL'nl nl" Ihe a￿lI.ti iJhjLLIivLS. ThL Lhdriti. LILLtLd rrbLmbL'T4. wh(Tr inilLEdL doitor4. 4CiLllti%t4. JlliLd profL%%ional% IspLLi¢ili%t nur%L.%. phdrm:ILi%t.s dnd diL'titi.'Ins I 'inil midiidl %tudLnrs. Thi% h.is hLLn a %ignitlLdnt inLfLJ_4¢ ()n la41 N'LJr. Durini bLLn aLIivL in prLSLniin&i iliniiJl dnd ba%iL fLSLarch in ihL' tILld nf PJLdidtriL ¥ndnLrin(?In￿. Jnd di41bLl¥%. b(Trih ID if% own mLmbLrs dnd thL Ii'idLf PJLdiJtriL LiTrmtnunitv. ML'iiihLr% (>l' thL S(KiL'IY JTL rCprl￿T]tcd iTrn i(Iiiimilt¢L% Ivlth i)thLr rcl'ilLd S0ilL"lic% liTr Ln.4UTL Llibsc Ii:ii%iiii. Jncl PLILdi:Ilrii L'nd(ILrini)l(ii?I TLpfLsiiiiatii>n in the dram Ing up i)r &TuidLline%. f_xaiiiplLS iniludi .NlC r.. F:uriipL'tin r.tidi)LrinL RL ILfL'IJLe NLtis1)rk IEIi
  • ERN i. Euri)pc-iii N¢1￿.(￿[L ()[ P.ILJiJtiiL RL5l.￿lb .71 thL" £uriipc.In NILdiiiiic.4 AgLllLy IIDpr-EfvIAI. DiahLtes UK. Q )'P Di.1bL'tLS BDJrd. SnLiL'tv Inr EndnLrinolo¥v and .4CDC. ThL Lhariiy ￿()rk.4 LIo%Llv H'iih ndti(Triial agLllLiL'S fi)r paLdiatriLS and is a(filiJlLd Miih thL Rii)':il CollL*bVL' ill P41diairi¢% an(5 Child HLalih. Brilish kiidcKriT]L .%{￿ILly. Ri)ial CcTrllL¥YL lif Phv%ii1￿% ihL .%I)iiLI)' fi)r Enduirinuli)gry'. ThL (IiiLlI' al%0 ￿-0[￿s ilo%L.l}' ￿7th P.IliLni Support Groups. %uih as 'f￿. Child GrO￿￿h Founddtion. 'fhL. 'l-urnLI SIxiLIy Support Ciri)up. 14ri1i.%h 'l'h!TuiJ FuundJtii)n. PiiuilJn' FuunJJtiun an(1 Lii'insi ￿'1th CAH. Pa%e 2 British Society For Paediatric Endocrinolo%v and Diabetes (A companv limited bv guarantee) Report of the trustees. (incorporating the directors. reporl) lor the vear ended 31 August 2024 Major areas of activity in support of the5c objeeliies In OctobLr ?1114 WL hcld our annual nx'L'ting in Gla4gow. li ￿'aS w¢ll :IttLnded and dLlii'ered an cxcLIILnt %Liinlitic pr()&ry.?mmL with d H'idL rdngL iTrf InpiL4 invLring thL. dLpth and biLadih nf PaLdiatriL cndncrinDlogN' and diabLtL dLIIvLfLd hv renoumed %peakLrs. inLluding many local dLIL&'aiL'% tTnm thL adult Jnd PiLdiJtriL LndDLrillL Lomn)unity. ThL BSPLD 211?4 A￿.￿l￿d% .SL%sinn hLld on thL SLcond daN' nf thL mL'L'tin¥ in whiih ihL PIL'nirv tilk hy thL JarnL4 M TdnnLr Aw#lTd winnLT W'.Is dLIii'LfLd by Dr Nick Shaw. detailin¥ his JournLy IhriTrugh()ut hi5 £￿LLr. Dr Shaw'* H'ork in thL :IrLn:i uf bonL Lndi)Lrinulogy beLOn￿ evLf llM)TL pfLvalent 41nd r¢Logni5ed as an importdnt cndoLrine sub PLLl&l1ity Ul'L'r thL l.ist deLldL. Other highlight% included Expert talk￿5)MPosiJ Ix 6) dehNeTed by expert %peakers i) Par".illel endoLrinolugv -￿￿ di41beie.% %es¥ioii% Per%c)ndl Prdiiiie se%%ion dnd 4 SJtellile SYmpv%ia Pre￿ent￿lIkVn4 froin previou% )'edr'% BSPED M'inneTS BSPED ?1)?4 AM'iird4 Ses5iun Top scurino :Ib.%traci% as oral communicalions Liuided pusler iours o Q'ME day including inleresling case presentations NursL and End()LrillL Prote%%ionals SL4.4iDn How do 19 ILndncrine & diabL"tLS) Pa%e 3 British Society For Paediatric Enduirinulv￿v and Diabetes (A companv limitcd bv guarantee) Report of the trusleeji, (incorporating the directOPts' rep()rt for the vear ended 31 August 2024 Ikev actii'itv 20?3.2024 Virtual PaLdidtriL LndoLrillL CTroup i ifpLCI N1¢ina¥Ld bi. SLnthil .%LnniJppdn Js POC Chair and supportLd bv Dine%h Ciiri ChlE OffiLL'r PnpulJr qu:IrtLrl! Ca%L pfL%Lnt-Ilion Ii'ith up i1Tr 711 [￿￿PIL fLgislL Ting for thL rnLLting% in !1}23 A￿,￿rdS Jnd yyranl. Oi'LfsLLn bv thL AW￿d¥ ConunittLL." Nadia Amin IChJirl. EieLUtIl-L CoinmittLL mL'mbL'Th and Clinildl CiTrii)iiiittLL Chair CurrLnl CJf¢Lnl% 41nd -iiv.wd RI SL'irih & Iniiiiv'itiiTrn Ay':ITd P.lidi'iinL EniliiL Tilll & Di-IbLtL.¥ Nur%L & AHP Au'41rJ J:IinL % Nl 'l'aiinLf ilii'drd i NuminJlii)n4 I'u[ ?()?5 will UPLn lollU￿.1ng this Ineeling CiinlLrLniL -1'141I'L I Ciflinl. PLLr RLN'ILII. B.SPEI) n(Tri%' running? d I'irlLiJI PLLr rLI'ILiI' pri)LL%% M'iih a nuiiihLr i)[ rLVjLlVS tJkiiig placL in ?(1?4 Including. LLiLL%IL'r. LLcds. Edinhiirbh aiid GlJ.%gw()ii' .£upp(yrl liir LSBLI IiiJ%lLf.% Ll)Iif4L lor nuT%CS IISPED lunilLd 111 .NursLS In ?11?J ID L()InplLle ihi¥ niir%L LndiKrinL ina%lLi% m(TrdulL HI)IllL 01-11LL AgvL Esliin.')lii)n SLiLnlilii ildvisot). Ci?TnIniiiLL L4%PE-D ihilil Piiil (?I' TnlLnin LCTrIIIII)iLleL 'l-Iibiih-i R.'mdL11 appuinlLd i(} ijnyi{?iny' LvmmiiiLe DLL 71171 NH5E Oul-patieni ReiO%efV Trdiisfurnialiun Proiir.'U￿I BSPED Lhair represented RC"PL"H i)n pri)gr'iImiie RQ PLH - BSPED be¢n ￿or￿"n&T cluseli. li iih theni un uilier projeil Cjrant 'ind PrpieL I liindiiig for )Il*S and bevond B.SPED .'ILIIvLly %¢Lkin&i idLJ% Jnd %UbT¥TLStion% I'rurn 114 mLnibLrs 11?r pr(iJL'IlN l() lund Tn Loming )'Ldrs. ThL kL!- LritLn'i ti)r 'iIi!' pri)JLLt 1.% thill if u'iluld briiig binLlil til BSPLD ..Ind ihL H'IJLI LndiKriiiL Ci)Iiiii)unity MLiiibLf%hip fLL% In ?11?4 B.qPED tLL.s inirL'.'I%Ld hj" Sf"; li* J itill i'ir!. rL l%(Tri).IblL £1 ?6 PLr l'iar B.SPED IllL IiIITrLI.%Iiii? IlJLluJL.S .1 IiuiiibLi vf l)LIiLlIl%. BSPED Clinical .Sludies Cwruiip DiLibitLN i DiabilL% LIK Tru74 pritiriliL%'. TN'pL ? diJbLIL% 111 LhildrLn .Ind %uuiiiT pci)plL - hiyTrhli&Trhi nijiice ILnl'il hL-Ilth .￿d p%N'ih()l(i&)ILJI iliiPJLI Ill l'i>un& PLI)pIc iipri)N ing DiabL'IL% EduLaliiTrn in LIIuL'lli(?ndl %Liiin&p Di'ibtrie.% UK Pr(?jeLt Gr.Ini lunded ?11?4 LOD]menied i L nder%l-lJ)din¥v InequJliues and Barriers to ALLe%%i]RL Diabele TeL'hn()l1)É7V iTh Llu"Idren .llld Yi)ungi Pt{)ple with TNpe l Di-lbeies Viiiie (Il Ihe Child 'ind Youni. Per44)n in Diabtle% 111)4- Lutnpleied Publiidtiun= BridLiin¥Tr ihe dig.iial th'i'ide EndoLrine INIHRI N(? lungei suppurted by NIHR due to CRN re%tructure DiNLus%innN rL'garding7 BSPED rLLiinin!T a ILSLarih fi)Lu. ThL plan is lo %L*t thi% up a% J ReseaTch SpLLial Intere51 Group Page 4 British Society Fur Paediatric Endocrinolo&v and Diabeles (A companv limited bv guarantee) Report of the trustees, (incorporating Ihe directors. report for the vear ended 31 August 2024 Priorilie.s idtntified for workplaD in 21124 l. SirLJnilining dLILIi?pii)Lnt {)[ Bspf.D siJndard% and ¥uidLlinc Guid.InLL l)n dei cli)piuent {)[ BSPED pJtiLnl inli)nuatiiyi) ILallcts. 3. BSPED Al .4lcruiLI t'ud tran%l*lti(iii.s dlld cdui:Ilion-Il SI￿d￿rIJ5 ()f paediatn"i Al 4. Ltsniributions to kev NIL I consultJlivns' cg- TepliLiinub- rcvicw lif Al guirJJnc¢ 5. Re-launLh OIGH AuLlit 6. Honing peer rei iew. pr()Le%% 7. Re%'iewin&Tr SIG% and lern)% of referenie 8. BSPED Pre-lvpe I diabeles oroLtp sel up RO).￿1 College of Paediatrics and Child Health Annual Professional .Meeting 21)24 ?7ih NlJrch 21)?4.. Face ID l¢lCC B.SPED %pecial inlcrLSt gn)up ￿￿p{)￿luM i) CoTnbiiied %L'5%iC)n ii'iih British PILdiJlrii Jnd Adt)IL4icnl B()ni Gruup 4 .spL'Jkers and 5 oral ci)mmuntLaiiuns -111 ab%lraLls .¥uhmitted: l invited gucsi Icciurc, 31?ral prL'%eniJtions al symposia, 3 shcirt POSlL'r prLSLntalions. ?4 a epostLIS Siummary of Clinical Cummiltee Activily 2023-24 'lThc Cliniial Cvmmitlee conlinues lo bL very pruduLIiN'L and meeL% regularl! in rL'moie furn￿1 which enables guod endanie. Cnminis%iLbning P4ieJi¢ilrii Di.'IbLILs & Enducrinologi= No lo Wales. Ni l & ScoLl4ind-Engldnd-Nl ISE Service SpLLifiLdtiun lor PdLdiJlriL Endorrincilugv should be publi5hcd shonly. AchiLI'cniLnt GuidLlini'. 51and￿d5 and posiiion slatcnK'nts SutLmLnt ()n u.4L Ut" CJnRH analuguL' RL1,ILl￿ l)f tc%t()%lLri)nL ¥*uiddnLI BSPLD 51and￿lL4 of PaLdidtriL L'ndOLfi￿. stfviLCS lupdalL review) Coniribuled to Surve>'s.' Disordered breaihing in PWS. fertilit! preservaiion in PWS. use of eleclronic gTowth chan {Gro￿￿h Sl(i-eihi¢s aPPTovedi NICE ¥uideline= AdTL￿1 in%ufficiLncv. TIDVA rLtinopJthv NICE rL'VIL?￿' Vami)￿ltsnL and Gii'inosthl ID DMD. NICE nk'thods Jnd procLSS ￿nual con%uli4tivn IldrLnJl insufliLiLnLy aLhievemenls PaLdiJtric Adrenal InsuifiLiLnLv %l¢n)id card translation= Poli%h."I'urki%h, GrL'L.k. Urdu. Rumanian alrLady ai'JilablL'. IXriibiL. ChinL%L, -s1(>v.￿a.1n Irliv.'iitlTlgV %LLI)nd r¥VlIM'Lri BSPED PaLdiatrii End()LfiiiL Nur%L SpLLiali51 CU￿1￿n(Y DevLlopinenlal Trramework IPeiLr kning. Karen Thompsonl Bspf.D Mi)rkiii¥r ¥Tr()up ()n s1'inJard% i)r LduLJtI(?n i)I' p'lLdiJtrii 'idrenal in%ufliLiL'IILy Paxe 5 British ,Svcietv For Paediatric Endocrinology and Diabeles (A companv limited bv guarantee) Report of the trustees, lincvrpuraling Ihe dinytors. report for the vear ended 31 August 2024 Cnminillec memhLr%hi J:Irod W(Trn&' Chdir" iliniial LoinmittLL KdihLI wr]￿hr.. DiJhLtL'S NursL RLPIL.4cntatii'c Nabil B(?uli)u4". Di¢ibLtLdLndoiiiiiL AIIiLd HL'ilth KLprL"Kllidtil-L .Saiah MiC￿rIsOn.. Di¥itdl & Infi)riiiJlii?n ()I-IiLtr ILlaniL KLrsI)J￿': Clinii411 CiUi(ILlinL% OfficLr 41mL'% LdH": Cliniidl StdndardN OtfiLLr Tr￿LW¥ll i() I coinplLILd iLrtns of offiLL I= JLniiifLr CJlN'Lrt. DiabLIL.s NursLlIllliLd I ILJlih RLpfL%LnlalivL AngL I:1 LuL-i%-I li fiLlIl.. Dig7itAI & Iiil()rmJtiuti 01-IILLr Pi)i)14 .SaihdL i.: Cliniial 81.Iiidard% oifiLL'r LLial InlLrc%l Lyrou Growih Di4order% Helen Siorr ThITI)id ¢iihL'nnL PLILisffim(hLLtham D.SD /.diiiab:i .Nlnhdn)Ld CAH l.'IdrLnal Nils KriinL HPAT Paul l)imitri Bills,IVhiiL'IPniiiaSJLhdLI' iii?11-?i)?s iii) I 111)5 ?{11 y- Trll?5 Tr{}ii)_?11?.fj l. CJri)u1h di4()rdLI NiliÉ)ndl LvuidLlinL%. LliniLal stand￿d%. Jnd p()siliun lraiLnk'nL%'. C-linical .%i.'Ind-Iiils ti)r rhl(Tl.' l lhLr￿1Pl. fi)r SL I'LfL PrimarN' IGF- I dLfJclL￿v & %LvLfL Iii%iilin rL'sistsnLe Po%ition %l:)temeni I"nr Ihe u4e ol. long aclin£ hGH Pft%ilion 4liileinent 'GrO￿'th horinnne ih¢rapi' In Sili'vr-Rus.%ell %vndrnme I SRS I beiween _ and 4 01 age Sh'ired care &Tuidelines Inr rhC;H iherJpi' i [Tpd'ited Nationdl ddvisnri. rnl¢%". Input & li:11son wilh editor%hip nl Ihr BINFC io updJle and correcl prescnbing puidance IOT hGII lor Noonan vndr(>inL I BNFC"_UPLlalLcI fL4uIt I 1s()ri' rolL inlo Lligibilili. inlL'ria l Ll)llivlli ()I' GLllI)tnii% Elig1:￿d L￿1V g?row1h fdilurl dia&Tll(Trs1iL £LllL pJnLI IpanLI Lligibililv updalid lulloivingtr .SICJ Inpul Ildi"i%i?rs' ri)IL l(> nLl%'biyrn gLnoiM' S¥MIlJLnLing prugrJmnK. ladvi.%Ld whiLh ¥L'nL% lo bL' InrludLd and dLI'L IopLd the v-Ilid:ItiiTrn %tr:ItLgvl RL.%L.'IfLhlaudil= Nali(ynal ileLtn)nii &?ri)wth Ll)Jn iiudit ThL SIG LSt'ihli4lied d w"iJrkingi ¥ryi)up iniludiTlg GRID irJineLS, RCPCH IiprL'%cnl'ilivn 'ind 51G nlLnibifs - LihiL% tipprui al (Trhiainid IF¥la%, 70.41 and prtTrJLLi oniYI)Ing' Thvrnid ReiTuI:Ir inieraLiion re %eLi)ndarv h.vwith!'Ic)irJism deteLliOll ICheeihanL knw., Pviers. ScboelllTh￿e1S, Wood i. EihiLS ppri)vul a%%Dciaied dala c(illeition I coillpilaiiiin nn¥?ning Page 6 British ,4iocietv Fur Paediatric Enducrinology and Diabeles (A compan) limited by guaranlee) Report of the trustees, (incq)rporating the directors. report) for the vear ended 31 August 2024 Audil C()niplLted Re-dudit of BSPF.D DSD skni)dard%- lo be pre%ented ai BSPED Oral. Lcarning Shared le4irjlin￿Tr Irom Case based disliissinn Qvanimation video Commenied a QI proJeLt on DSD animdli(M video- BCH I due to be pre%enled in the nexi SIG meelingi 4. AdrenaVCAH on￿y(lin￿7 proll￿1 on TLal world Lvlli'clion of pdticnts w'ith CAH I num. 14 UK Lentre51- presentation of prelim rL%uII.4 al BSPED 2024 0 Support and LIK link to LLNS@IT adn'nal tunM)uTh in childrLn thnd !'0unÈ P¢Tsons F.eedbaLk lo NICE guidclinr r)n adrLndl in%uffiLienLy= identificalion rnanagcment Public¢ilion (If fir%1 UK naticTrnal paLdiiilric Lraniopharyngionu guidLIiDL in knncLt DiibetL& & EndoLrinolo¥y OpLning7 ol- phas'L. .1 r￿d1>MilLd conlrollLd lrial lor ihL USL. ol SL'lmi'laJ)ulidL in ihL' use ol acquirL.d hypoihalamic iTrbLsilv al Gn,Sl l Jiid Birmiiigham Ii)LfL:1SLd inlLrnaliun.Il inlLfL%I in I IPA'f - Chile. ML'XICU, Nether141nd5. Eslonia. CLeLh Republi 1.3 J'ear inaly515 ()I' I IPA'I. outLoinL'% Tho￿. in prubrL5S Collab(TrrJiion ￿'1(h Princc55 maxi￿ Centrc i UireLht) lo look al uul¢onK's of opliL pdthw'av glionu palil'nls with GHI IGF- l abn()tInLilitiL ML'tnbers pdrtiLiPJting in varivus for a - ESPE SLiencL S}Inpv%ium nn Hiy*tha]amic Dysfunction in Childhi)od. In¢Lrndli(IDal PostgrradualL' Cc>urse in Clll'ldhiNJd Craniophar¥'ngril- B.SPED.sIan(I￿d% and ¥uidLlinc5 Guid'inLL Iin d¢iLI()PTnLnl ()[ B.8PED p.'IliL'nl infonvLilivn ILlnLts BSPED ill ¥lLroid Lard trJi)%l'itivii EduLaiiunJl .%landaid% ctrl. paidiJliii Al () GiJiTr¥lL Aiidli'lii% Iv rLViLH' IvL.b%iiL LngvJgLillLni B.SPED LinkLdlii prL'%L'llL L'iinirihuti(In% tti klv N IC"L LonsuIt:Itii)ns.' I'LplI7￿b. TLI'iL14' Ot Al ¥?IiidJnLL". LIL (Tr RL-I;ILillLh ()[ CIH Jludit Hi>iiing' PLLr rii'i¢￿ yrc)LLS. Rei'iewirb¥ SICi% .'Ind iernis i>f ref¥renie Diabetes DKA LJILulJl(?r D'￿ Le:iih Lie.Iliir_ heing updLiied NILE Teplii_uniab loping Lonsulidlion- I ID67.591- in progress RLiin(TrP¢iihi' l NCJ) J) l - Au¥ _ NHS S.'IfLty' ILani - PdllLni %￿flt} RLpfLSLntJii()n ()n NHSL Oi'Lrsi¥hr giiiiup HC-I. 5-)'L:Ir plan- ioinii)LniLd Apnl ?1}14 CJlRI.T rLI'ILM' PrL-TIyL I diabL'ILS &Trvup112 mLmbLrs14 ndtion%l B5PEI) Ivebsile Dei'elopment ThL B.%PEL) M'i b%iiL ￿'al rL'-dLI-LIopLd ind l.)unLhL'd In J'inu41Tr 711 111 lind Lf)nliiiuL% tc) bL" nliiint.IinLd bv BSPED ThL I¥LhsilL 1% Iliwllid ilt.. Pri?% idin&7 UP-ti)-d.IlL U%L.ful & rL.IL'N.'Inl inl(?mi;IliiTrn ii) enci)ur:Ig'L IlklbTC ul. IhL" .&ite b). hL'ilih priil'L%411Tr11al.4 .'15 well .1S PJIiLnl%/LLifL'r rilLililating ii)niniLinii'itton & Lollaboratii)n arn[Tri}￿ BSPFD iiien)bL'T Pr(iiiii)tin¥y uur %PL"LiJII) aTiLI WiiLlv nalii)nJll% Jnrj InlLrnaliunally Pii)iidingi £1 u%cr Iriciidl) e.¥. %n)art plione IriLndlv ver%i(Trn Pa%e 8 British Svcietv For Paediatric Endocrinology and Diabeles (A compani, limited by guarantee) Report of the tru*itees' lincorporating the directors, report) for the vear ended 31 Augusl 21124 Other supported actii'ities The .SoLiLtI' %upport¢d J nuIn￿Trr vf iTriher.1clivilic% in 2023 - ?0)4 whiLh inLluded: L.'pd-Ilin& LIK %t'ind*ird% for paedi'itnl L"ndoiriDologv (April ?(1741 On gFvingi suppvrl to the rnainicnJnc¢ ul- Ihc BSP￿D Wehsitc rL-dcN'elopinLnl 11()lal ¢051 of £10,642) FundLd Md%lLr* nur%ingT ILTrufsLS in PaLdialriL Endi)criniJliJ&?v. LDiidvn Si)uihbank. Llnivl'rsilv (£1 ?.¥501. This iJkc4 plai Iverv . }'L"Jr% Jiid IN'L hai'l Lui)ImillLd i() lur IhL JILXI r()und in !{1)4 76 CL)11.Iboralic)n w'ith d InLdiidl juurnal (Endocrinvl()g)'. DiabL"Ic.4 and Melabolism La¥e reports) for ￿￿MberS Iv publi%h their rLSLAfLh al a rLduLed raiL 'I'rdvel and diiLndanLL g7ranls for junior membcrs presenting. Ihcir rLsearch work at annual cc)nlerenLe8 lo ihL' .¥um of £7.101 EduLational prizes I research award% of £33.3(X) SpoDsor8 There 1% dedicated finaiiiiJl suppott l() the S()ciet!' Iroin spon%i)i% ITi)In ihe phiirinaceuucal indu%try. In ?1124 ihe p..￿llershiP, %pDiisnrslup and eI)gLLgemenl ()pponunities were ll)odemi¥ed and %tralified inio iiidividu-d iompiinenl% repldLing ihe prei'i()u% 4 iier% ()[ %uppon with diflerent lei'els ()[ henefil% wiihin eaLh iier. lienis ihrc)ughoui ihe ve. available fur purLh&se inLlude meiiiber webinarlenLiiune￿'41e1Ier Jdieni4ingl%eLlion of the partner resourie libr.'Iry. Annudl n)ILtingT% UPPLlrtuniiiL.S InLludL saiellitL 4)'mpu%iun￿eKhlblIorlI￿j,￿d loguldLlegale bdi. Io&TO. 'I'he inaj(Iriiy uf ihe punsorLJ fuiiding tu %upport thL' Annual MLLting. gr0￿h hornii)nc audit. rL4LdlLh grant and Lduialiuntil training L.s4iuns for di)Irors and nu[￿c￿. SOML of ihe funding is uscd for Clinical CommittLL. EILLLIIII'L CominittLL and Clinical SpLLial Interest Group a¢tivitiL'S. l.unding also contributes to thc running of the SociLty and SecrCi￿at fees. liinaneial reTr'iew It 1% Ihe poliiv vf Ihe Societv Ici maint.1in U￿rL.%￿JCtLd lunds. which are the fTCC rL'4eTves ol Ihe Lharilv. Thc re%crves are hLld dt d ILvel Ihal en%iirLS the luturL. finiinciJl i'iJhilil! uf ihL' Soiicl).. "lThJi lei'el 1% dLxmL'd to be onc thai LqU&iles lo miiiiinuili ul. apprc)ximaiLly one vcdr % LXPLndilurL.. N'i?11 14 of thL [in￿ncIal sl.'IlL'TncllLg indiLdtc% Ihdii IhLfL are Ll.116.4.-195 un[¢s￿]LILd fund% as al .1 l Au¥u%i 21124. Thi5 prui'idL.4 %urriiiLni fund4 tu LUVLr IrknthJg'L'illLnl, ￿dn)InIs￿￿l1￿n d suppiirt L05t5. Pa%e 9 British Society For Paediatric Endoirinolv&v and Diabeles IA cDmpanTr' limited bv guarantee) Report of the trustee%' linc 70. Respi>nsibililies and basis of report As IhL Lhllrilv (ni4lc"L'% ol thL' LuinpJn%' I4ind Jl%o ILS dirLLtors fi)r ihl" purpose% ufLiimpany Id￿.) vou dre rc%pc)n%ibli for Ihe p[LpI￿allUn ol thL linancidl %lJiLinLnL% In aLLordaniL uiih ihL IL4UitLmL'nls ol thL CornpdniL% Jxit ?OU6 1'ihL )(K16 ALL'I. HdvinLF Snd b'loor 87 Kenton Road Harrow Middlesex HA3 OAH 29 Junc 2025 Pa%ell British 4iucietv For Paediatric Endocrinolo&v and Diabeles {A compani, limited bv guarantee) Statement of financial activities (incorporating Ihe income and expenditure account) For the vear ended 31 August 2024 Llnrtslrictcd 2024 ?1123 Income In¢()min¥￿ rL.SUUILL% trorn ¥LnLrdting' tunds.. AiliN'iliLS lor 'LnLr-Ilin¥y lujids Ii)LoillL I'ri)m ini'i%lInLIIIN 37).1164 71.46? 37?.1164 ?1.46? -1?7.X611 4,64fi Total inL'ibme 391.)?6 11?.5116 Expenditure C"(i%1s Lil. gpcnL r'itinL lund.%.' C'nNi ()1" g¢neialinLI lund% E.xpendilure on Ll)ariidble ')Llii ilies OthLr ()5.947 ?(1g.?_A6 6.8YS 65.947 l(19. ? 46 6.¥Y5 7IX,577 7,611 Total expendilure -44).117X 34?.1178 ?117.54? Net mvvemenl in funds 44.Yfi4 Rei(InLilidtiiin of fund5 Toial I'und% broughi I'oFN4'¥ird 1.111 i.Y47 1.01 l.Y47 Y66.9X_ Tulal I'und% Larried furm.ard I.IK>i.395 l.Ohi,iyS 1.1111.947 ThL iratLillLnl i)f fin-In¥idl diliVIIiL'% inLludL% all vain% IussL% in thL yLar .'Iiid ihLILforL a SLpar:ItL' St.'ItLnk'nl nt" Inral rLLI)¥¥ni%Ld ¥T-iin% :Ind Io%%L.s ha% niit bL'Lli pfLP.'ITLd. All ijf thL dlKIi'i am(?unL% fLldtL 10 innThnuin¥ ailii-itiL4. The notes on pa£es 15 10 20 form an inte%ral part of thvbe financial statemen Page 12 British Societv Fur Paediatric Endocrinolo£v and Diabetes {A compani. limiled bv guarantee) Balance sheet as at 31 August 2024 21)24 2023 Current assets Dcbii)r% CJsh Jt bank and in hand 37.llx I -15.711? 989,566 1.1195.961 .1125 ?68 Credilors: amounts fallin% due within one year (32.5661 (13.121 Net curreDt assets 1,1)63,IY5 1,011,947 Net assets 1.1)6.1.195 l.(111,947 CharitTr' Tr"unds LiirL%triLILd tund 14 .1)63.-195 .Ul1.947 Total funds ,lJ63,-395 .l)I l.Y47 ThL Balance ShLet continuLS on thL following page. The notvi on pa%es 15 to 20 foTm an inteRrJl part these fmancial slatements. Pa%e 1.1 British Societv For Paediatric Endocrinolo&v and Diabeles (A compani. limited bv guarantee) Balance sheet Icontinued I Tru.stees statements required hv the Companies Act 21M16 for the vedr ended 31 August 2024 bi 'ippiu%inb ihL4L finaniial %lalLnicnl% ITu%IcLS iTrf ihL LUlllPdllN W't hLi¢b!' LcTrlltm= lal iK'it for ihe Neur slated above ihe conipani. ￿.￿5 eniiiled ID the e.iemplion ionl'etted b). 5erlion 477 01. Ihe Comp￿Ie% Ait ?Illlfi; Ibl that no nnlice ha% beeti deposited ai ihe regislered ol-fice ol" the Comp￿%, pur%udnt lo seLlion 476 01 the Compdnie Acl IIIIIA reque%iing ihai an audii be innduLted l.or Ihe year ended I l Augusl ?11? J. IL l thal aLkni)IvlLd&'L iyur rL%piJn4ibilitlL% ti?r'. I l ) L'nsuriiis ihJt Ihi iibiiip-In%' kLL'P% pr()PLr aLLouiiiingTr rL*iirds whiLh Lon)plY M'ith %L'Lliiin _IXb ol" IhL Ci)Iiip.'IniL'% Acl I:. I prLpcirinL fin4iniial %lJlL TnLlli.% uhiih ¥ii'L d Init" and lair ¥'iLM' i)f ihL' %lJlL' (If dffJir¥ vf ih¢" L(?mpdny Jt ihL' end (If Ihe IinJnLial vl￿ uf it% surplus or dLliiil (or ihL' i'Ldr ihLn LndLd in JLLiirJ-InLL 14'1th thL fLqUiILmLnl% ul. 5L'Lliuns .IY4 dnd 3(}5. and u'hiih oihL'TlI'i%¢ iuinpl}' with ihL' proi-i%iiin% of thi CoinpJniLf Ait 'lMIfi rLlJtin&7 io findnLldl stalLmLnts. so far as appliLablL' tu thL Lumpany. -I'hi'¥L linaniial st-ItL mLnlN arL PTLpafL.d iii aLLordanLL wilh ihL' .%pL'cial pri)vi%ivns ol Part 15 ul. IhL Ci)mpJnJL% ALI ?11116 r¢ Idling if) %mall Li>inpdniLN. 'rhi I"Iii:IllLI:Il st:ItL'lnL nls ￿'lft :IppfuvLd hv ihL hii.lrd ijn 79 JuiiL ?11?5 aiid %i&?nLd 4)n il¥ bLh.Ill" hy Dr Fi(Ina Regan Trea.4urer. Tru%tee Re%istralion number 070U39113 The notes on paRes li to 20 forni an integral part of these financial statements. Page 14 British Society Fvr Paediatric Endocrinology and Diabetes IA compan), limited by guarantee) Notes to financial statements for the vear ended 31 August 2024 Aceounling policies The priniipal 41iiL)uniin¥ poliiie5 are surninJrised below. The aiLouniing poliiies haNe been applied Lonsi51enilv throu&houl the year and the preceding vear. Basis of accounting ThL tiiianLldl %tatLIIILlltb has'c bL"Ln pr¢pared in a¢¢ord.InLe ALCI)unting and rep()rting bv ChariiiLs." .SiatLment ()t RLLOlI)nK'ndLd Pr-ILtiLL 'ippliLabli Iv Lh41ritl¥% PTLI)ariiJ¥ theiT LILL(Truni% li) :ILLord4lnLL with thL l.in¢lnLl411 Rep()rtin￿ Si4ind4wd 4ippIiL41blL in thL UK 'ind RLpublii of IrLland IFR.S 1021 IL.ffL'Lhi'e l Januduy ?015) I Ch.￿illL5 .SORP IFiLg I ()))}. thL Fin.'InLial R¢￿)rts.ng .Stsndard appliLable in dK. UK and RLpublic ()f ITeland IFRS 10)14ind thl Ch￿IlL% ALI ?01 I. Brili%h Socielv Fur P¢lLdialriL Endocri￿1vgY and Diabetes ineels the definilion of 41 publiL benefil entity undLr PRS IU? Assets and li.IbililiL% litc iniliiillv rLxvbmised ai historical cost or Iransdciion %'alue unless otherwisL' %laled in the rel¢i'anl aLC(Truntiiig pi)lici' nolcl%l. ThL Iru%tCeS Lon.4idcr ihthl ihLrL are no material uncertainilies aboui thc I'rus1'5 abililv Ii) conlinue as a going conLcrn. For the reporting yLar thL' Lharitv updatLd thL' pre%L'ntation of of its cate¥otie5 of inLomc and L'xpcndiiufL' .40 lo beiier rLfl¢Lt its LurrL'nl UPLralions. Where rL'le%'11 nt ihL Comp￿dI1v¢. am()unts hive a150 bccn align¥d to tIu"5 pfL5cnlation. This has had Tho AmpaLt on the T¢PQrtLd surplus or nct a55Lt POSition for thL' Cutrent or iompiif4iiive year. The LJnanLI:d sldlejnents are presented in %ierlAng which 14 the funciioudl curTenLy vf the LI￿1[y. 1.2. L"ashllow The Lharitv has lJkLn a(Ivl¢ nlagc i)f ihe ¢.¥empiion in FRSIII? from I1￿ re4uircmcnl li) pruduLL' a LJshflow Nlatemrni because il is a srnall charily. 1.3. Incoming resources All ininii)ing rLsoufLL"5 are includLd in the sialeii?ent uf financial activitics when the Lhan'DJ' is entitlLd iu th¢. iniome and the ￿}￿UnI Lan bL quanlified wilh reasonable accuracv. 'I'IK. Ivllowing speLifiL policies are applie4J io pJrtiiu]￿ Lalegi)ne% ul. inco￿￿.. Voluntarv incnme 1.% re¢eJved by way ol grani8. donJiion4 and gitis and is included in l.ull in the staiemenl or rinan¢ial aclii'ities when receivable. Ciranl4 ￿,here enliilemenl 1% nol conditional on the deliverv of a specifi¢ PLrl'orman¢c by Ihe chan"ty. arL' recogni5ed whLn ihL' chan'iv bcconK'% ￿￿OndItIOnallY Lntitled lo thc grani. DunalLd 5LfViLL% ￿(1 Idiililils ITILludLd ai ihe valuL' lu ihL Lhdritv ￿,here this can be qU￿til1Ld. ThL' vAIuL' or LfviLLS PTOI'idL.d by vulunleL'fs has nut hL"i'n iniluded. Cjifts donated for Te&ilc inLludcd Js incuming Te50urces within Jctivities for gencrliting lund5 whL'n they 501d. IncomL frorn invcstrnLnts is includLd in the vear in which it is receivable. Page 15 British Society For Paedialric Endocrinologv and Diabeles IA compan), limited bv guarantee) Notes tn financial 5tatemcnts for the vear ended 31 August 2024 1.4. Resource.$ cxpended pendirure 1% recooni%ed on an accrual as a liabilit%' 1.% Incurred. Eipenditure include5 any VAT ￿'hICh Cdnnoi be fullv recovered. .Ind is reponed &% part the expendiiure io wkllch il relaies. C()%l% uf ¥LnLraliiiL luiid% LL?Inpri.%L ihL iv.s1% d%S1)iiJILd with JtlrdLling viTrlunlJr!' inLI?mL and Ihl i()%15 01 Iradin lor I"undr'u%ing purpu%LS In¢ludiiig IhL ihJrilN' % %hop. Charil'iblL' L.XPLnditurL' Ll)mpri%L.% ihuKL LU.%l% iniurfLJ hi. Ihl iharil!, in IhL dLlivin' ol. ils acliviliL% Jnd %LfviLLS l(>r lis blni IIL IiifiL4. li iniludL% buih ii)5l5 Ih'il ian bL' -IlloidlLd dirLLiI J. li) SULh .'ILlii'ilies and th(Tr5e Ll)s1% ul- In iiidirLi( iiJlurL niLL*%￿l. l(> _%uppiiri Ihiin. Support LO%t.S th0sL Ll)Nt% 11)LUThLd diTLLilI' tn %upp(Trrt i)f L.XPL'ndirure tsn th¥ ()bj¢LI.% ()f ihL' Lhuritv iniludL pri)JLLI IIILin4lg¢'mLnt. LeJ%ing A%sel% obi.'iined under hire purLh.Ise iointraLls and finanLe leases iapil.Ilised a% i￿￿￿1ble J.¥%ei4 and depreLidied L)Ker ihe shorier uf ihe ltrrni and ihvii usel'ul liie4. ObliLTaliun% uiidei %uch aqTeeinenls .'Ire inLluded in irediivrs nei of the IAnJnie iharLYe allvialed to I'ulure periuds. The fIn￿lle eleinenl ol Ihe renial pa)F]ienl 1% ih:Ir£ed to the proliT and 105.5 ai¢ouni %0 io produie conslani periodic late¥ of Ch￿ge on ihe nel oblig:Ilion5 i)ul.4tandin&T in e-iih period. Actii'ilie.s for generating fund5 [Inrestriiled funds 2024 'rutal 20?3 Total Spnn%or IthLIIIIIL Membei%hip 5ub%iription% AniiuJl NIL'Liing' Ini(?1￿. 1 !8.-$93 4X.CIA5 ?14.lSyy 4%.665 )14.8yy 157.11?I -177.0fi4 -￿?7.￿61) Income frum ini'e5tments Ilnrestricted fund.s ?024 Total ?023 Total Bank iniLfL%I rLLLivdblL 21.46? 21.462 4.646 ?1,4h2 ?1.4()? 4.()46 Page 16 British Society For Paediatric Endocrinolo&v and Diabetes IA compan): limited by guarantee) Notes to financial statements for the vear ended 31 August 2024 Cnst of generating fun(Ls Unrestricted fuDds 2024 2023 Total SLLfLl4iriJt fLLS WLh4ilL' expLndilure Sponsor commi%%ion Credit l￿d Lharges Sundr), LXPLn%L'S 46.978 10.fy42 5.5511 46.978 111.64? 41.607 11.5118 6.690 1.112X 1.133 1,133 6).947 65,Y47 61.357 Expenditure on charitable aclivities - bi fund type Ilnrestricted lund 2024 2023 'rutal Annual meeting 'rrainin RLSLarLh ??11.11146 21)9.581 .Iiix> 7.9x9 1 S.SS11 3_3,I(Ml ?69.!36 269.?36 ?18.572 F.xpenditure on charitable aclivitiLs - hv activitv Actii'ilies undertaken direclli. Grant funding aflivities Support 2024 Total 2023 Total Annu:Il mLeting Tidining Re5earLh ?12.-$118 7,41)1 15.X'511 177 2211,086 1 S.XS11 3.1.-I(Ml 9119,5X3 i.liixi 7.9119 ?1? 51)X 56.551 177 ?69.?16 218.57? Pa%e 17 British Societv For Paedialric EndoCrinul￿v and Diabetes IA compan) limiled bv guarantee) Notes to financial slatemcnts for the vear ended 31 August 2024 Other Unreslricted funds 2024 Total 2023 Aici)unl4illLV_ Inc)nthlv bLKJkkiLping Aiiiiui)laiiL% Vidrlv fin'inLiJI %lJlLmLn15 Insuranie -1.166 3.366 2.2611 l.Y61) I.IS6 75 75 6.895 ,Inalysis of support Cl)sLs Annual moeting 21124 Tulal 177 177 177 177 Enlplovees There wer¢ nil einplovee% duriny? Ihc vear. Ni) s'11.Iries or W41gL"% hai'L bLL 11 p.'iid to thL IrustLL'% during tht i'e'ir. io. Taxation The Lh:ITiIy'% -ILliN ille% 14111 isiihin ihe e.KeIiiplii)IL% .'Irriirded bv ihv priii i%i()n% i)[ P..irt 111 Iniiiille Tiix ALI ?11117 1)r S¢¢liiin lfil? i)I' the T&lX.'Ili()ii i)[ C h.Irge.1ble C¥Lii11S ALI IYV? li) the exleni thdi iheNe dre Jpplivd iu 11% ¢harilJhle iihjeLt%. ALL(IrdinLvl%". Ihertr 1% n(? t4ixaliiiD i￿.￿￿e in the%e aLLI)Ulhls. ii. Debtors 2024 2023 OthLr dLhior.% Prcpavnicnt% Jnd aLLrued inLUJI)e 24.-3Y7 111115 -17.11%1 -15.7112 Pa%e IS British Society For Paediatric Endocrinology and Diabetes (A company limited by guarantee) Notes to financial statements for the vear ended 31 August 2024 12. Creditor%: amounls falling due within one l'ear 2024 21)23 ALcrual% and delerrcd inLnme 13. Analy%is of net assets between funds Unrestricted runds Total funds Fund baI￿LL5 at 31 Augusl ?0?4 a% represented by-. Current asset5 Current liabilitie 1.09.fj,961 11? 5661 l.1)95.961 (.32.506) 1.()63.395 l.O()3,395 14. Unrestricted funds At 31 Au%ust 2024 C)pening Incomin% l)utgoin% lund5 resuure r¢5ources General reseri'es I,011.Y47 393.5?6 1342.U78 1.1)63.-395 Purpose5 of unrestricted funds The purpii%L nf thL unrL4lriilLd funds 1£ to adN'ance eduialion in piediil tric cndiKrinology and related %ubjLiIs by prumoiinby rL'SL'￿Lh £U)d disSLI￿n￿ll￿g thL U%Lful rL"%ulis 1)[ %uih [L￿41fLh. 15. Restricted funds At 31 August 2024 npenin% runds RestriLtcd funds. Page 19 British Society For Paediatric Endocrinology and Diabetes (A compan)" limited by guarantee) Notes to financial slatementS for the vear ended 31 August 2024 10. Compan), limited hi. guarantee Brilish SuLiLiV kur PJLdiauiL EndiTrLrii)cilugv aiid DidbL'IL¥ 1% a LVl1lP'￿5. liinilLd guJraniLL Jnd diCL)rding'lN' diTrL% niTri hai'l d sharL LaPllJl. Ei'L'rv mL'mbir (Trf Ihe Li?Tnpan)' undL"rtdkL% Iv Lcininhiill .suih amriuni may hL n'iiuirld n()l Lxcei'dingi £ I lu ihL I%%Ll4 of thL Lharil.'IblL Ll)Inpan% in ihL Ll'cnl ()( ils bLing ￿'Ound lip w'hilL he or shL is li inLmbLr. c)r within iinL yLaf LIIILr hL l)r %hL' LL&%LS io bL' 4 InL'iiibL'T. Pa%e 20